Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studies of Esophageal Metaplasia Using a Novel Antibody: Reversibility of Columnar Metaplasia by Proton Pump Inhibitor

NCT00161200 is registered in ClinicalTrials.gov with University of Medicine and Dentistry of New Jersey as lead sponsor.

NCT NCT00161200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studies of Esophageal Metaplasia Using a Novel Antibody: Reversibility of Columnar Metaplasia by Proton Pump Inhibitor
Lead sponsor
University of Medicine and Dentistry of New Jersey
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2002
Completion date
October 31, 2006
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal metaplasia